Amy Furlong

Amy Furlong is a seasoned executive in the biopharma and healthcare clinical technology sectors, currently serving as President of the Board of Directors at IDDI and as a Strategic Advisor at Studion. With a robust background as an Independent Executive Consultant since June 2021, and previous roles including Chief Operations Officer at YourEncore and various executive positions at ERT, Amy has demonstrated expertise in operations, M&A integration, and product line management. Amy’s leadership in establishing compliance and quality programs has significantly contributed to operational efficiencies and corporate growth. Educational qualifications include a B.S. in Biology and a Master of Science in Pharmaceutical Sciences with a focus on Regulatory Affairs from Temple University.